miércoles, 16 de agosto de 2023

Quizartinib Dihydrochloride: New FDA Approval for Acute Myeloid Leukemia (AML)

https://www.cancer.gov/about-cancer/treatment/drugs/quizartinib-dihydrochloride?cid=eb_govdel_cancerinfo

No hay comentarios:

Publicar un comentario